Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine.
about
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingElderly patients and inflammatory bowel diseaseReview article: the management of autoimmune hepatitis beyond consensus guidelinesPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UsePersonalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicineDrug methylation in cancer therapy: lessons from the TPMT polymorphismPharmacogenetics in inflammatory bowel diseaseLeucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazideAssessment of Thiopurine-based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic LeukemiaAnemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprineThiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.A comprehensive molecular interaction map for rheumatoid arthritis.Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine modelClinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing era.Clinical pharmacology of inflammatory bowel disease therapies.The genetics of rheumatoid arthritis: influences on susceptibility, severity, and treatment response.Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.Principles in pharmacogenetics.Candidate gene approach for pharmacogenetic studies.The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.The emergence of resistance to targeted cancer therapeutics.Pharmacogenomics: marshalling the human genome to individualise drug therapyPros and cons of medical management of ulcerative colitis.Azathioprine: current status and future considerations.Cancer pharmacogenomics: SNPs, chips, and the individual patient.Iron, anaemia, and inflammatory bowel diseases.SNPs in cancer research and treatment.Pharmacogenomics and IBD: TPMT and thiopurines.Pharmacogenetic approaches to rheumatoid arthritis.Review article: exploration of the genetic aetiology of inflammatory bowel disease--implications for diagnosis and therapy.Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response.Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical PracticeGenetic susceptibility to iatrogenic malignancy.The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis.The thiopurines: an update.
P2860
Q24632749-97AEABDF-6628-4DAF-B1E0-938C133D14BDQ26768270-A016F25D-62F4-4B58-ADC8-486DAB8CE695Q26864272-558386F0-296E-4E38-8DDC-8EA228053349Q28068930-C7C93C20-BAA7-4ED7-98C4-97C1D86AE396Q28082746-780CD5FB-AD28-4CC1-AEB5-541EC5742001Q28212325-E9DD0DBB-88A5-45CA-8BA9-20A8AB594FC5Q28246002-8CA53C9D-596F-4186-989A-37AE5737E5DBQ28361611-CDAFCAAA-DC43-4620-804D-17EC211AF5B6Q28612763-4836DA78-9332-4E59-B9CA-419A12397459Q33349234-9B332207-C7BD-47C4-956A-3A797B94CB82Q33380531-5511E151-BAC1-4D29-B476-6C46580DA6E1Q33394134-380CCD19-8F51-49BC-ABBC-C7A99B94A55BQ33564313-88DE0046-38E6-4D7A-A246-BD071C5798CDQ33603164-7327134B-2E73-449E-9624-D11AB4644525Q34026161-86849BE0-A35F-4F43-A388-CD749AA7B32AQ34082718-789A6F68-4234-43DD-8238-6E1CAA05D412Q34108788-99A650F0-555F-42BF-8538-DBACA1975642Q34428463-27E0A8E5-CF90-428B-A5D7-A17987B3C2A5Q34447018-F96FC595-98E9-4108-833D-F89FBC3DE507Q34459885-441763B3-DF51-4D2C-96B7-7F33CCBC0F99Q34558122-E155AC05-50DD-467B-93C6-5E6E4E6B2E12Q34609133-C7B74437-3688-4F15-8F8B-E26629E6CC11Q34609157-EC328D63-CE0D-4152-B9A9-430189D73BECQ34837015-FE9E690A-811D-4ED1-ABDB-05B8BDF6ECFEQ35090217-C8C95B9A-CD17-4E56-A337-46AFC69EF3E7Q35100726-BB2ACC54-492B-41FB-ADBD-905614A92833Q35130911-094446DC-C957-4E46-BB74-E18CD01DD1A4Q35553873-1A7FDF60-FB02-42D0-8216-D76A688E1A05Q35596692-F829A5C3-5557-4ACE-8666-78D4B1D139CCQ35670196-D62F1571-4111-4902-B394-848EEBE99CCFQ35787643-F970E05E-D671-4085-B227-069ADB2693C2Q35834289-7B5AB709-19CB-43B7-8BAA-9B79EA189C35Q35880358-98B10190-F894-48EE-8B48-5FF0FE0AD5CBQ36055251-E3362D07-BED6-42BD-B01C-AD0404DE4D22Q36120104-8F360D23-45C9-4D31-84BB-46111D83BE69Q36192796-18D8E82C-3471-47F6-B56F-7DD867DFF122Q36223417-9E62E2B9-A60F-4968-AB83-D99056BF907CQ36249238-799F6A4E-E184-4DF0-A2DC-5A0B108A4350Q36286418-6EE18CE3-C727-4302-AFCD-89798F933002Q36305435-AACC0E64-8E6F-4E83-8C71-0E9E783B647D
P2860
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@ast
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@en
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@nl
type
label
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@ast
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@en
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@nl
prefLabel
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@ast
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@en
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@nl
P2093
P1476
Thiopurine methyltransferase g ...... re toxicity from azathioprine.
@en
P2093
Collie-Duguid ES
Pritchard SC
P304
P356
10.7326/0003-4819-129-9-199811010-00007
P407
P577
1998-11-01T00:00:00Z